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Abstract: Importance: Therapeutic inertia (TI) is the failure to escalate therapy when treatment goals
are unmet and is associated with low tolerance to uncertainty and aversion to ambiguity in physician
decision-making. Limited information is available on how physicians handle therapeutic decision-making
in the context of uncertainty. Objective: To evaluate whether an educational intervention decreases TI
by reducing autonomic arousal response (pupil dilation), a proxy measure of how physicians respond to
uncertainty during treatment decisions. Design, setting, and participants: In this randomized clinical
trial, 34 neurologists with expertise in multiple sclerosis (MS) practicing at 15 outpatient MS clinics in
academic and community institutions from across Canada were enrolled. Participants were randomly
assigned to receive an educational intervention that facilitates treatment decisions (active group) or to
receive no exposure to the intervention (usual care [control group]) from December 2017 to March 2018.
Participants listened to 20 audio-recorded simulated case scenarios as pupil responses were assessed by
eye trackers. Autonomic arousal was assessed as pupil dilation in periods in which critical information
was provided (first period [T1]: clinical data, second period [T2]: neurologic status, and third period
[T3]: magnetic resonance imaging data). Data were analyzed from September 2018 to March 2020.
Interventions: The traffic light system (TLS)–based educational intervention vs usual care (unexposed).
The TLS (use of established associations between traffic light colors and actions to stop or proceed)
assists participants in identifying factors associated with worse prognosis in MS care, thereby facilitating
the treatment decision-making process by use of established associations between red, green, and yellow
colors and risk levels, and actions (treatment decisions). Main outcomes and measures: Pupil assessment
was the primary autonomic outcome. To test the treatment effect of the educational intervention (TLS),
difference-in-differences models (also called untreated control group design with pretest and posttest)
were used. Results: Of 38 eligible participants, 34 (89.4%) neurologists completed the study. The mean
(SD) age was 44.6 (11.6) years; 38.3% were female and 20 (58.8%) were MS specialists. Therapeutic
inertia was present in 50.0% (17 of 34) of all participants and was associated with greater pupil dilation.
For every additional SD of pupil dilation, the odds of TI increased by 51% for T1 (odds ratio, 1.51;
95% CI, 1.12-2.03), by 31% for T2 (odds ratio, 1.31; 95% CI, 1.08-1.59), and by 49% for T3 (odds ratio,
1.49; 95% CI, 1.13-1.97). The intervention significantly reduced TI (risk reduction, 31.5%; 95% CI,
16.1%-47.0%). Autonomic arousal responses mediated 29.0% of the effect of the educational intervention
on TI. Conclusions and relevance: In this randomized clinical trial, the TLS intervention decreased
TI as measured by pupil dilation, which suggests that individual autonomic arousal is an indicator of
how physicians handle uncertainty when making live therapeutic decisions. Pupil response, a biomarker
of TI, may eventually be useful in medical education. Trial registration: ClinicalTrials.gov Identifier:
NCT03134794
DOI: https://doi.org/10.1001/jamanetworkopen.2020.22227
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Abstract
IMPORTANCE Therapeutic inertia (TI) is the failure to escalate therapy when treatment goals are
unmet and is associated with low tolerance to uncertainty and aversion to ambiguity in physician
decision-making. Limited information is available on how physicians handle therapeutic decision-
making in the context of uncertainty.
OBJECTIVE To evaluate whether an educational intervention decreases TI by reducing autonomic
arousal response (pupil dilation), a proxy measure of how physicians respond to uncertainty during
treatment decisions.
DESIGN, SETTING, AND PARTICIPANTS In this randomized clinical trial, 34 neurologists with
expertise in multiple sclerosis (MS) practicing at 15 outpatient MS clinics in academic and community
institutions from across Canada were enrolled. Participants were randomly assigned to receive an
educational intervention that facilitates treatment decisions (active group) or to receive no exposure
to the intervention (usual care [control group]) from December 2017 to March 2018. Participants
listened to 20 audio-recorded simulated case scenarios as pupil responses were assessed by eye
trackers. Autonomic arousal was assessed as pupil dilation in periods in which critical informationwas
provided (first period [T1]: clinical data, second period [T2]: neurologic status, and third period [T3]:
magnetic resonance imaging data). Data were analyzed from September 2018 toMarch 2020.
INTERVENTIONS The traffic light system (TLS)–based educational intervention vs usual care
(unexposed). The TLS (use of established associations between traffic light colors and actions to stop
or proceed) assists participants in identifying factors associated with worse prognosis in MS care,
thereby facilitating the treatment decision-making process by use of established associations
between red, green, and yellow colors and risk levels, and actions (treatment decisions).
MAINOUTCOMESANDMEASURES Pupil assessment was the primary autonomic outcome. To test
the treatment effect of the educational intervention (TLS), difference-in-differences models (also
called untreated control group design with pretest and posttest) were used.
RESULTS Of 38 eligible participants, 34 (89.4%) neurologists completed the study. Themean (SD)
age was 44.6 (11.6) years; 38.3% were female and 20 (58.8%) were MS specialists. Therapeutic
inertia was present in 50.0% (17 of 34) of all participants and was associated with greater pupil
dilation. For every additional SD of pupil dilation, the odds of TI increased by 51% for T1 (odds ratio,
1.51; 95% CI, 1.12-2.03), by 31% for T2 (odds ratio, 1.31; 95% CI, 1.08-1.59), and by 49% for T3 (odds
ratio, 1.49; 95% CI, 1.13-1.97). The intervention significantly reduced TI (risk reduction, 31.5%; 95% CI,
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Key Points
Question How do physicians handle
uncertainty whenmaking live
therapeutic decisions?
Findings In this randomized clinical trial
of 34 neurologists from Canada, an
educational intervention showed a
significant 31% reduction in therapeutic
inertia comparedwith the control group.
Pupil dilation, a marker of autonomic
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Abstract (continued)
16.1%-47.0%). Autonomic arousal responses mediated 29.0% of the effect of the educational
intervention on TI.
CONCLUSIONS ANDRELEVANCE In this randomized clinical trial, the TLS intervention decreased
TI as measured by pupil dilation, which suggests that individual autonomic arousal is an indicator of
how physicians handle uncertainty when making live therapeutic decisions. Pupil response, a
biomarker of TI, may eventually be useful in medical education.
TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT03134794
JAMA Network Open. 2020;3(12):e2022227. doi:10.1001/jamanetworkopen.2020.22227
Introduction
Therapeutic decision-making requires an individualized balance of the safety and efficacy profiles of
different agents with either imperfect information or uncertain response of that choice.1,2One
outcome in decision-making in the context of uncertainty is therapeutic inertia (TI). Therapeutic
inertia is characterized by suboptimal decision-making not to initiate or intensify treatment when
treatment goals are unmet.3-5 Therapeutic inertia affects 60% to 90% of physicians caring for
patients with chronic conditions (eg, hypertension, diabetes, or multiple sclerosis [MS]).4-7
Suboptimal decision-making is associated with worse clinical outcomes and higher health care
costs.3-5,8 A randomized clinical trial onMS care reported a 70% reduction of TI in neurologists, using
a short (<5 minutes) and simple (application of the traffic light system [use of established
associations between traffic light colors and actions to stop or proceed]) educational intervention.9
For MS care, overcoming TI corresponds to appropriately switching from a first-line agent (eg,
glatiramer or interferon) to a high-efficacy treatment (eg, fingolimod or monoclonal antibodies)
when given both clinical and radiologic evidence of disease progression.9-13
Recent studies reported that decision-making in the context of uncertainty is associated with
autonomic arousal, as measured by pupil dilation.14,15 In particular, phasic pupil size increases are
associated with suboptimal or erroneous decision-making involving high uncertainty.16,17However,
the association between autonomic arousal and therapeutic decision-making in the context of
uncertainty is unknown. A better understanding of pupil dilation as a marker of an autonomic arousal
response and TI may facilitate the development of decision-aid tools or other educational
interventions to overcome suboptimal or erroneous decision-making in the context of other chronic
medical conditions (ie, hypertension, diabetes, and dyslipidemia).
In this randomized clinical trial, we investigated (1) the relation between autonomic arousal
responses and TI, (2) how a previously tested and effective educational intervention9 affects
autonomic arousal responses and TI, and (3) whether autonomic arousal responses mediate the
association between the educational intervention and TI. We usedMS care as an appropriate model
for complex therapeutic decision-making arising in the management of chronic medical conditions
using a previously tested and effective educational intervention to reduce TI.9 Consistent with the
details in the protocol for the Canadian study, we hypothesized that our educational intervention
would decrease practitioner uncertainty about therapeutic choices, as reflected in decreased
autonomic arousal responses, and thereby lead to an improvement in therapeutic
decision-making.14,16,17
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Methods
StudyDesign
In the initial study conducted in Argentina, 90 neurologists who provided care to patients with MS
were randomly assigned to the TLS intervention (n = 45) or to the control group (n = 45). A 70%
reduction in TI after the TLS intervention was found compared with controls (odds ratio, 0.30; 95%
CI, 0.10-0.89). In the present study using a similar design, we added the assessment of pupil
responses to determine how the TLS would decrease uncertainty and TI. We conducted a
randomized clinical trial of MS experts and general neurologists who care for patients with MS
practicing at 15 outpatient MS clinics in academic and community institutions from across Canada.
We randomly assigned participants to an educational intervention group or to a usual care control
group fromDecember 2017 toMarch 2018. The educational intervention used the traffic light system
(TLS) to reduce TI in themanagement of MS. The control groupmade therapeutic decision-making
without being exposed to the TLS intervention, in line with current standard practice. Randomized
group assignment and allocation concealment were controlled by Qualtrics. Participants were not
aware to which group they were randomized. Investigators were also blinded to the treatment
allocation. Themean (SD) time of study completion was 44.9 (6.7) minutes and participants received
CAD$450 (equivalent to $350). The trial protocol is available in Supplement 1. The protocol was
amended on October 25, 2017, to add pupil measures as a primary outcome. This amendment was
approved by the Research Ethics Board of St Michael’s (which became Unity Health Toronto in May
2018). Data were analyzed from September 2018 to March 2020. This study followed the
Consolidated Standards of Reporting Trials (CONSORT) reporting guideline for randomized clinical trials.
Details are available at ClinicalTrials.gov (NCT03134794) and elsewhere.9
Inclusion Criteria and Participants
Neurologists actively caring for patients with MS across Canada were invited to participate by email
sent from the Canadian Network of MS Clinics and NeuroSens (Lind Publishing Inc) (Figure 1). These
networks comprisemostMS neurologists in Canada. Participants were recruited fromDecember 13,
2017, to March 2, 2018. Participants who completed a postresidencyMS fellowship were classified as
MS specialists. Physicians seeing less than 1 patient withMS permonthwere excluded from the study.
Participants provided written informed consent. The study was approved by the Research Ethics
Board of St Michael’s Hospital, University of Toronto.
Figure 1. CONSORT FlowDiagram
38 Participants assessed for eligibility
20 Randomized to receive TLS
18 With complete pupil data
2 With incomplete pupil data
12 With complete pupil data
2 With incomplete pupil data
18 Analyzed
2 Excluded from analysis
12 Analyzed
2 Excluded from analysis





TLS indicates traffic light system (use of established
associations between traffic light colors and actions to
stop or proceed).
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Educational Intervention
The Traffic Light System
We applied a previously proven effective TLS intervention9 to facilitate the identification of patients
at high risk of disease progression (based on clinical and imaging evidence of disease progression)
introduced by case scenarios. The TLS supports the decision-making process by use of established
associations between traffic light colors and actions to stop or proceed.9,18-20 For example, in the
context of this intervention, a red light represents high risk and triggers a stop and think action,
whereas a green light represents low risk and a triggers a continue the same strategy action. A
previous study reported that the TLS can interrupt automatic behavior and lead tomore optimal
decision-making.21 In our MS care model, the TLS aims for the red traffic light to indicate a warning
sign of disease progression and a switch from a low-efficacy agent (eg, interferon or glatiramer) to a
more effective disease modifying treatment (eg, monoclonal antibodies).10-12 The TLS aims for the
green traffic light to indicate stability in a patient and following a good clinical course (eg, no relapse
and stable activity on brain imaging), therefore requiring no immediate therapeutic changes.
Data Collection and Study Flow
The study progressed as follows: (1) collection of demographic and practice-based information from
participants, (2) participant completion of behavioral experimental procedures, and (3) participant
completion of 20 simulated and standardized case scenarios (10 before and 10 after the
intervention). We used simulated case scenarios reflecting common situations in clinical practice that
were previously designed and validated by our research team (G.S. and J.O.) and MS experts, 16 of
whom directly assessed the presence of TI.9 All simulated case scenarios were presented auditorily
(via headphones connected to the computer) to avoid interference of visual stimulation and
automatic eyemovements with pupil responses. Themean (SD) duration of case scenarios was 35.4
(7.1) seconds (range, 27-50 seconds). For each simulated case scenario, we identified 3 periods during
which critical information was provided (eTable 1 in Supplement 2). The first period (T1) provided
critical clinical information (present and previous clinical relapses, type of relapse, and/or symptoms).
The second period (T2) informed about the neurological status of the patient (Expanded Disability
Status Scale). The third period (T3) provided critical brain imaging information (number and nature of
new lesions, gadolinium-enhancing lesions). The period before the start of case scenarios (T0)
served as baseline, while the fourth period (T4) represented the final segment in which standardized
questions (eg, “What would you do? Please select one of the options”) were asked in preparation to
the treatment options (Figure 2A). Compared with the baseline T0, we expected an autonomic
arousal response during critical information periods T1 through T3 and little response during T4.
Based on previously reported associations of risk and ambiguity aversion with TI,6,7we
considered also their relation to autonomic arousal responses and TI, using establishedmeasures in
the financial domain.22,23 Briefly, ambiguity aversion is defined as a dislike for events with unknown
probability comparedwith eventswith known probability.22Ambiguity aversionwas assessed asking
participants to choose between a known 50/50 option (an urn with equal number of blue and red
balls) providing $400 or $0 and an option with unknown probability of the same outcomes. Risk
aversionwas assessed by asking participants to indicate theminimal certain payoff theywould prefer
over a gamble with a 50/50 chance of winning $400 or $06 (eAppendix in Supplement 2).
OutcomeMeasures
Therapeutic inertia is defined as lack of treatment escalation despite evidence of disease
progression. We defined disease progression as the combination of a clinical relapse plus the
presence of 5 or more new lesions (T2 or fluid-attenuated inversion recovery sequences) or at least 1
gadolinium-enhancing lesion in follow-upmagnetic resonance imaging scans.10,11Using the
combination of clinical relapse andmagnetic resonance imaging activity is consistent with evidence
regarding the risk of treatment failure in patients receiving interferon beta.24 For each of our case
scenarios, we determined TI as a binary variable (present vs absent; primary outcome). A secondary
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outcome included TI greater than or equal to 25% of responses, meaning that participants did not
escalate treatment when recommended in at least 1 of 4 simulated case scenarios.9-12
Experimental Procedures
The study was conducted in an ambulatory clinic–type setting to increase ecological validity. Room
temperature, light conditions (100 lumens), and participant sitting positions were held constant. We
calculated z scores for pupil time-series scored within each participant to allow comparison of pupil
dilation between and within simulated case scenarios, critical periods, and participants. The mean
pupil size (measured at T0, ie, 1500 ms - 500ms before scenario onset) was taken as pupil
baseline.25 For each simulated case scenario, we estimated autonomic arousal responses by
Figure 2. Study Design and Time Period Illustration
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A, Participants answered demographic and practice-based questions and provided risk
and ambiguity preferences. Next, they listened to simulated case scenarios. Each
scenario was followed by 6 therapeutic choices, which remained on the screen until the
participant selected 1 of them. After the first 10 simulated case scenarios
(pre-intervention), participants were randomized to the intervention or the control
group. All participants performed another 10 simulated case scenarios. B, The black dots
represent the peak pupil size within each period used to compute pupil responses (pupil
peak for each periodminus mean baseline at period 0 (T0). Peaks were determined
similarly for both groups across all periods and case scenarios. T1 indicates first period
(critical clinical information); T2, second period (neurological status of the patient); T3,
third period (critical brain imaging information); and T4, fourth period (standardized
questions were asked).
JAMANetworkOpen | Medical Education Effect of an Educational Intervention on Therapeutic Inertia in Neurologists With Expertise in Multiple Sclerosis
JAMA Network Open. 2020;3(12):e2022227. doi:10.1001/jamanetworkopen.2020.22227 (Reprinted) December 16, 2020 5/13
Downloaded From: https://jamanetwork.com/ by a UZH Hauptbibliothek / Zentralbibliothek Zuerich User  on 01/20/2021
subtracting themean baseline pupil diameter from the peak pupil dilation during each critical period
(T1-T3) (Figure 2B).15,26 Further details are available in the eAppendix in Supplement 2.
Sample Size
Our study was underpowered to evaluate differences in TI between groups.9 The observed 15.5%
absolute difference between groups (unadjusted results)9would require a sample size of a minimum
of 78 participants per groupwith an α = .05 and β = .2. The power to determine differences in phasic
pupil response in relation to TI was 99%.
Statistical Analysis
We applied 3 analytical approaches: (1) comparison of autonomic arousal responses across critical
periods, (2) treatment-effect analysis evaluating the association between autonomic arousal
responses and TI, and (3) a mediation analysis to assess how the association between individual
participant characteristics and TI may bemediated by autonomic arousal responses. For the first
approach, we used nonparametric tests (Wilcoxon rank sum test for continuous variables andMann-
Whitney test for categorical variables). For the second approach, we compared high vs low arousal
between groups stratified by intervention period (preintervention vs postintervention). We used
generalized estimating equations to assess relationships between the variables of interest with TI
accounting for clustering (repeated observations on participants) across all TI scenarios for each time
period. This analysis controlled for the predefined explanatory variables age, specialist status (MS
expert vs general neurologist), years of practice, risk preferences, and ambiguity aversion as
identified in previous research.6 To test the treatment effect of the educational intervention (TLS),
we used difference-in-differences models (also called untreated control group design with pretest
and posttest).27 This model allowed us to measure the treatment effect of our intervention by
comparing the change over time (posttest minus pretest performance) between the intervention
and control group. For the third approach, pupil dilation for each participant and case scenario was
tested as a mediator. Thus, the mediation analysis evaluated whether individual autonomic arousal
responsivity accounted for the benefits of the educational intervention on TI. Mediation analysis is a
technique commonly used in the social sciences to explain a relationship between an independent
variable (eg, demographic variables) and an outcome via a third variable (calledmediator).28,29We
measured whether the effect of our intervention on TI was mediated by pupil-indexed
autonomic arousal.
All tests were 2-tailed, and P < .05 wase considered significant. We used Stata version 13
(StataCorp LLP) and SAS version 9.4 (SAS Institute Inc) to conduct all analyses.
Results
Participant Characteristics
Of 38 eligible participants, 34 (89.4%) neurologists completed the study. Themean (SD) age was
44.6 (11.6) years; 38.3%were female and 20 (58.8%) were MS specialists. Participants had amean
(SD) of 12.5 (12) years of experience and assessed amean (SD) of 23.1 (16) patients with MS per week.
Of the 34 participants who completed the study, pupillary data were available in 30 (88.2%)
participants. Two participants in each group had incomplete or missing pupil data (Figure 1). Table 1
presents baseline characteristics of the study population.
Participants showed risk-neutrality in our measures of risk attitudes and theminimal safe
amounts participants preferred over the 50/50 gamble did not differ between groups (Mann-
Whitney P = .14; mean [SD] control: $175.7 [$45.2]; mean [SD] intervention: 211 [78.8]). Nineteen
(55.9%) participants showed aversion to ambiguity in the financial domain. There was no difference
in baseline pupil data between groups for each simulated case scenario (2.82 mm vs 2.96 mm;
Mann-Whitney P = .57).
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TI was present in 50.0% (17 of 34) of participants in at least 1 case scenario, representing 7.7%
(42 of 544) of all individual responses that assessed TI. Non-MS experts had higher prevalence of TI
compared with MS experts (11.5% vs 5.2%; P = .01).
Arousal Responses and TI
Overall, pupil size increased for each period relative to baseline (F test of overall significance
indicating whether a linear regressionmodel provides a better fit to the data than amodel that
contains no independent variables, all P < .001). The results remained robust after adjustment for the
prespecified covariates (P < .001).
Themultivariate analysis adjusted for age, sex, MS expertise, risk preferences, ambiguity
aversion, preintervention vs postintervention period, and intervention group by period (Table 2)
showed that pupil dilation was positively related to TI for all critical periods (T1 to T3). For every
additional SD of pupil dilation, the odds of TI increased by 51% for T1 (odds ratio, 1.51; 95% CI,
1.12-2.03), by 31% for T2 (odds ratio, 1.31; 95% CI, 1.08-1.59) and by 49% for T3 (odds ratio, 1.49; 95%
CI, 1.13-1.97). As expected, there was no association between pupil dilation and TI for T4 (odds ratio,
1.07; 95% CI, 0.86-1.34) as no critical information was provided, which may suggest a relation
between TI and the arousal elicited by critical clinical information.
Our results were robust to using secondary outcomemeasures (Table 2). Together, stronger
autonomic arousal responses at critical periods were associated with stronger TI. For TI equal to or
greater than 25%: for T1 (OR, 1.53; 95% CI, 1.11-2.12), for T2 (OR, 1.33; 95% CI, 1.07-1.63), for T3 (OR,
1.51; 95% CI, 1.13-2.00).
Table 1. Baseline Characteristics of Participants
Characteristic
No. (%)
Total (N = 34) Control (n = 14) Intervention (n = 20)
Age, mean (SD), y 44.6 (11.6) 40.5 (8.5) 47.5 (13.5)
Female sex 13 (38.2) 6 (42.9) 7 (35.0)
Practice characteristics
MS specialists 20 (58.8) 6 (42.9) 14 (70.0)
General neurologists who care for patients with MS 14 (41.2) 8 (57.1) 6 (30.0)
Practice setting: academic hospitals 28 (82.4) 6 (42.9) 14 (70.0)
Years in practice, mean (SD) 12.5 (11.8) 9.4 (9.5) 14.7 (12.9)
≥20 Patients with MS seen per week 15 (44.1) 4 (28.6) 11 (55.0)
Author of a peer-reviewed publication in the last 12 mo 22 (64.7) 10 (71.4) 12 (60.0)
Risk preference, minimal safe amount, mean (SD), $a 196.5 (68.5) 175.7 (45.2) 211 (78.8)
Ambiguity aversionb 19 (55.9) 8 (57.1) 11 (55.0)
Pupil data, mean (SD), mmc
Pupil size
Baselined 2.90 (0.87) 2.82 (0.35) 2.96 (0.99)
Peake 3.27 (1.10) 3.15 (0.5) 3.35 (1.35)
Response (peak minus mean baseline)c 1.60 (1.42) 1.69 (1.34) 1.54 (1.47)
a Risk preference was assessed by asking participants
to indicate the minimal certain payoff they would
prefer over a gamble with a 50/50 chance of winning
$400 or $0.
b Ambiguity aversion is defined as a dislike for events
with unknown probability compared with events
with known probability. Ambiguity aversion was
assessed asking participants to choose between a
known 50/50 option (an urn with equal number of
blue and red balls) providing 400 or 0 dollars and an
option with unknown probability of the same
outcomes.
c Pupil data were available for 30 participants. Pupil
data reflect means across the study after
interpolation and calculation of z score.
d There were no differences in baseline characteristics
between groups.
e Only including critical periods: the first, in which
clinical presentation was provided, the second, in
which functional status was provided, and the third,
in whichmagnetic resonance imaging findingswere
provided.
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Abbreviations: MRI, magnetic resonance imaging; OR,
odds ratio; T1, first period; T2, second period; T3, third
period; and T4, fourth period.
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GroupAllocation andAutonomic Arousal Responses
Pupil size did not differ significantly between the TLS and control groups before the intervention but
did so after the intervention for T2, T3, and T4 (Figure 3). Overall, the multivariate analysis showed
that in the postintervention period, participants in the control group had significantly enlarged pupils
(as a continuous variable) compared with the intervention group for T2 (β, −0.46; 95% CI, −0.90 to
−0.01; P = .049), T3 (β, −0.63; 95% CI, −1.04 to −0.22; P = .004), and T4 (β, −0.75; 95% CI, −1.12 to
−0.37; P < .001) (eTables 2 and 3 in Supplement 2). No differencewas observed for T1 (β, −0.23; 95%
CI, −0.64 to 0.19; P = .47). The adjusted analysis for the dichotomized pupil response (maximum-
peakminusmean-baseline0.1 difference in z score as a high autonomic arousal vs <0.1 difference in
z score low autonomic arousal response) showed similar results (hazard ratio control [reference
category], 10.1 [95% CI, 8.2-12.0] vs hazard ratio TLS, 7.2 [95% CI, 6.2-8.1] vs LR control, 4.5 [95% CI,
1.6-7.5] vs LR TLS, 3.2 [95% CI, 0.8-5.5]; P < .01]) (eFigure 1 in Supplement 2). Together, these data
suggest that the educational intervention has a protective effect, which extends into the period
when participants made decisions in the context of uncertainty.
Educational Intervention and TI
In a previous study,9 the educational intervention showed a significant reduction in TI. To assess the
presence of a treatment effect on individual TI, we used the difference-in-differences analytical
strategy (eTable 2 in Supplement 2). We found that participants in the educational intervention
group had a significant reduction in TI (risk reduction, 31.5%; 95% CI, 16.1%-47.0%) compared with
the control group (eFigure 2 in Supplement 2). Linear regression analysis adjusted for participant age,
sex, expertise, risk preference, and pupil dilation showed that for every therapeutic decision, there
































































































































































Pupil-linked autonomic arousal responses (peakminus
mean baseline) are shown separately for intervention
and control groups, stratified by the intervention
period. Lower responses in the intervention group
extend to T4, in which no critical information was
provided, whichmay suggest that the protective effect
of the intervention extends into the period when
participants made decisions in the context of
uncertainty. T1 indicates first period (critical clinical
information); T2, second period (neurological status of
the patient); T3, third period (critical brain imaging
information); and T4, fourth period (standardized
questions were asked).
a P < .01 for the comparison of pupil responses
between control and intervention groups.
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was a significant TI decrease of 5.0% (−5.0%; 95% CI, −0.8% to −9.3%) in the intervention group.
There was no interaction between the education intervention and MS expertise (β, −0.518; 95% CI,
−3.936 to −2.901; P = .23). The difference-in-differences analysis revealed no evidence for
confounding endogenous effects (eTable 4 in Supplement 2). Together, these data replicate the
previous findings that the TLS intervention reduces TI.9
Autonomic Arousal Response,Mediation, Educational Intervention, and TI
Autonomic arousal responses mediated 29.0% of the total effect of the educational intervention on
TI (eFigure 3 in Supplement 2). The direct effect of the educational intervention on TI was −3.5%
(95% CI, −9.2% to 3.5%). Other factors (eg, age, sex, risk preference) had a nonsignificant or a
negligible effect. Further details are in the eAppendix in Supplement 2.
Discussion
To date, the role of autonomic arousal for therapeutic decisionmaking remains unexplored. In the
present study, we addressed this gap in the framework of therapeutic MS care decision-making, with
a focus on decisions not to escalate treatment when recommended by best practice guidelines (ie,
TI). We analyzed pupil dilation as amarker of autonomic arousal14,15 and found that both continuously
measured pupil dilation and dichotomized high vs low pupil responses were associated with TI. For
every additional SD of pupil dilation, the odds of TI increased by 31% to 51% depending on the clinical
information being provided. Even though our study had low statistical power and Canadian
neurologists show comparatively little TI,7we estimated that participants in the control group would
have reduced TI by almost a third if they would have been randomized to the intervention group.
Our data suggest that the interventionmay ameliorate TI by reducing autonomic arousal responses
to critical information. Pupil dilation mediated the effects of the educational intervention on TI
(explaining 29% of the total mediated effect).
Physician uncertainty may be a factor in rapid pupil-linked autonomic arousal responses,
affecting behavioral choices14 and the updating of beliefs with presented evidence.30Our
educational interventionmay reduce autonomic arousal by reducing uncertainty and thereby
facilitating alternative behavioral strategies. Specifically, the warning function of a red traffic light
may help emphasize the need for switching to a more effective agent 9 andmay concurrently boost
the physician’s confidence in the therapeutic decision.
Relevance for Clinical Practice
Therapeutic inertia commonly affects physicians caring for patients with chronic medical conditions
such asMS, diabetes, and hypertension.31-33 This studymay help increase the understanding of how
physicians make therapeutic decisions in the context of uncertainty. Critical clinical information
increases autonomic arousal and stronger autonomic arousal responses are associated with
suboptimal therapeutic decision-making (ie, TI). Moreover, the inertia-reducing effects of our
educational intervention appear to bemediated by reduced autonomic arousal responses. Wemay
now be able to identify physicians who are making frequent suboptimal decisions (>25%) and to
estimate potential reductions in TI from novel educational interventions. Furthermore, autonomic
arousal responses may serve as a marker of the effectiveness of those education interventions. This
marker is unaffected by demand effects or cognitive biases. Consequently, our findings may help
create other avenues to tailor educational interventions and formal risk-assessment training to
decision-makers (medical students, family doctors, and specialists). This approachmay help optimize
treatment decisions for other more prevalent chronic diseases and lead to improvedmedical
education and better patient outcomes.
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Limitations
This study has limitations. First, pupil size is not a standardmeasure in clinical practice. Second,
autonomic arousal responses may have different triggers and effects than the ones we tested. Third,
given our small sample size, imbalances between groupsmay lead to residual confounding.We used
a statistical approach (eg, generalized estimating equations and mixed models) to address these
imbalances. Fourth, simulated case scenarios may not truly reflect therapeutic decision-making in
clinical practice. Fifth, the TLS we used is just 1 example of an intervention suitable for MS care. Other
interventions may be needed andmore effective for themanagement of other prevalent acute and
chronic conditions.
Despite these limitations, our conclusions are strengthened by a randomized intervention
design showing an autonomic arousal–mediated link between an effective therapeutic intervention
and therapeutic decision-making made by physicians who care for patients with MS (eFigure 3D in
Supplement 2).
Conclusions
Therapeutic inertia is a common phenomenon in clinical care, associated with worse outcomes and
higher health care costs.6,8,34 The TLS education intervention appeared to help facilitate optimal
therapeutic choices by ameliorating the uncertainty associated with clinical information and
decreasing TI. Autonomic arousal responses represent therapeutic uncertainty, which was
significantly decreased among physicians randomized to the TLS intervention. Our findingsmay have
practical implications for medical education, therapeutic decision-making, and patient outcomes.
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